Presented at the 78th ASRM Scientific Congress & Expo, SGF’s research team offers reassurance for intended parents growing their family with the use of an egg donor and can offer guidance to patients pursuing elective egg freezing.
New research from Shady Grove Fertility (SGF) conducted with Donor Egg Bank USA offers reassurance for intended parents growing their family with the use of an egg donor and can offer guidance to patients pursuing elective egg freezing.
“Egg donation helps fulfill the dreams of parenthood for individuals and couples faced with infertility,” shares Phillip A. Romanski, M.D., M.Sc., SGF physician. “At SGF, we pride ourselves in providing evidence-based fertility care; therefore, our research team conducted a study to help guide intended parents who are growing their family through egg donation.”
The findings of SGF and Donor Egg Bank USA’s study reassure patients using eggs from donors ages 21 through 32 yielded a similar ongoing pregnancy rate.
“We decided to conduct this study because some data have suggested an increase in chromosomal errors among the youngest infertility patients,” adds Dr. Romanski. “Thankfully, we didn’t find cause for significant concern among recipients of eggs from younger donors.”
The study found that the pregnancy outcomes for each year of donor ages between 21 and 32 were comparable to donor eggs age 29.
The retrospective cohort study was conducted by SGF physicians Phillip A. Romanski, M.D., M.Sc., and Kate Devine, M.D., and Melissa Stratton B.A. and Wayne Caswell M.S. from Donor Egg Bank USA. The SGF research team looked at egg donor recipient cycles at Donor Egg Bank USA between 2013 and 2021. In total, the study looked at 3,678 donor egg cycles.
Dr. Romanski joins the SGF New York physician team this fall and provides patient care at SGF’s Manhattan location. In spring 2023, Dr. Romanski will open SGF New York’s SoHo location. He is board certified in Obstetrics and Gynecology and board eligible in Reproductive Endocrinology and Infertility. He specializes in third-party reproduction and egg freezing as well as diminished ovarian reserve, premature ovarian failure, and reproductive surgery. He serves as the Director of Research for SGF New York. At this year’s ASRM national meeting, he will receive the “Star Reviewer” award from Fertility and Sterility for his exemplary service to the journal, and his research will also be awarded the “First Prize Video Research Award” by ASRM.
SGF is one of only a few private practice fertility centers in the country to employ a full-time dedicated research team, which operates under Director of Research, Kate Devine, M.D., a board certified reproductive endocrinologist who sees patients at SGF’s Washington, D.C., K Street location. Dr. Devine also serves as the Executive Medical Director and Chief Research Officer at US Fertility, the largest network of physician-owned and physician-led fertility practices in the United States, of which SGF is a founding partner practice.
As a premier IVF and fertility center of excellence, SGF continues to make a sustained commitment to clinical research and educating physicians in training.
To learn more about ongoing research being conducted at SGF, visit http://www.shadygrovefertility.com/research.
About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With convenient locations throughout the U.S. and in Santiago, Chile, SGF accepts most insurance plans and makes fertility treatment accessible and affordable through innovative financial solutions, including 100% refund guarantees for eligible patients. SGF is a proud partner practice of US Fertility, the largest physician-owned and physician-led partnership of top-tier fertility practices nationally. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.
